LEP and rheumatoid arthritis: Some studies have already analyzed the role of adipose tissue cytokines in the response to treatment in RA, especially TNFi and IL6 inhibitors (IL6i), and have found that IL6i can modulate these adipose tissue cytokines (especially leptin), while this modulation is not so evident in the case of TNFi drugs [19,28,29,30,31].